Bio Break: How to Ensure Targeted Drug Delivery Hits the Right Spot

Resources

Bio Break: How to Ensure Targeted Drug Delivery Hits the Right Spot

Topic: Bio Break

In this episode of Bio Break, Nick Allan and Joris van der Heijden tackle the fascinating challenge of targeted drug delivery. When administering drugs to specific areas in the body, how can we be certain they reach the intended target? Nick shares an exciting example involving an intranasal device designed to deliver drugs precisely to the olfactory cleft—an area located between the eyes.

From initial bench modeling with plastic nose prototypes to sophisticated human trials, the episode breaks down the multi-step process used to confirm drug deposition. Learn how techniques like using food coloring on prototypes and delivering radiotracer technetium-99 for imaging helped refine their approach. Nick dives into the advanced use of CT scans and radioactivity mapping, followed by real-world testing with medical-grade methylene blue and ENT scope visualization.

The team showcases how the integration of engineering, human trials, and medical-grade testing leads to reliable results in targeted delivery systems. Discover why these detailed studies are crucial for verifying that drugs reach their destination, ensuring safety and effectiveness.

Whether you’re a medical professional, device developer, or simply intrigued by how cutting-edge drug delivery works, this episode offers insights into the science and technology behind targeted solutions.

Key Topics Covered:

  • Real-world examples of ensuring precision drug delivery
  • Targeted drug delivery to the olfactory cleft
  • Using radiotracers like technetium-99 in imaging trials
  • Employing methylene blue for visible deposition tracking
  • Challenges and solutions in intranasal device testing

How to Ensure Targeted Drug Delivery Hits the Right Spot

A laboratory or engineering workstation featuring a high-precision stereo microscope mounted on an articulated arm, positioned beside two computer monitors displaying 3D CAD models or imaging of a complex mechanical or biomedical device. The workspace also includes a keyboard, mouse, and a metallic container, all situated on a clean white desk in a dimly lit, modern lab environment.

In a sophisticated world of ever increasing complexity, we need our tools to evolve alongside us and assist in complex decision making, allowing us to understand the consequences of choices ahead. Computational Modelling and Simulation (CM&S) is emerging as an essential tool in building evidence for medical device development.

Three engineers are assembling or troubleshooting a large industrial or medical device prototype in a workshop. One person is seated in a wheelchair, another is standing behind the structure, and a third is kneeling on top of the machine for internal access. The workspace includes tools, laptops, electronic parts, and a large diagram of the device on the wall.

I routinely engage in the development of prototype medical devices. These prototypes typically incorporate at least one printed circuit board (PCB) installed within a plastic or metal enclosure, featuring numerous connections to external components through various connectors.

A laptop on a wooden desk displays a digital document icon on its screen. Beside it, bold text reads "Design History Files Explained," highlighting the topic of regulatory documentation in medical device development.

Nick and Joris break down what a DHF is, why it’s required, and how it plays a vital role throughout the development lifecycle.

Two colorful paper boats—one red and one yellow—float on a blue background with illustrated white waves beneath them. Bold text reads "From Idea to Impact," symbolizing innovation and progress in medical device development.

Nick Allan and Joris van der Heijden revisit one of StarFish Medical’s most successful Pathfinder journeys, showcasing how a bold research concept evolved into a fully realized clinical diagnostic device.